(Q34421159)

2 August 2017

Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials (English)

1 reference

2 August 2017

1 reference

5

Lehana Thabane

1 reference

2 August 2017

6

James D Douketis

1 reference

2 August 2017

Jennifer A Pereira

1

1 reference

2 August 2017

Anne M Holbrook

2

1 reference

2 August 2017

Lisa Dolovich

3

1 reference

2 August 2017

Charles Goldsmith

4

1 reference

2 August 2017

Mark A Crowther

7

1 reference

2 August 2017

Shannon M Bates

8

1 reference

2 August 2017

Jeffrey S Ginsberg

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

24 May 2005

1 reference

Annals of Pharmacotherapy

2 August 2017

1 reference

2 August 2017

39

1 reference

2 August 2017

7-8

1 reference

2 August 2017

1188-1193

1 reference

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

2 August 2017

1 reference

Controlled trials in single subjects. 1. Value in clinical medicine

21 January 2018

1 reference

Case studies, single-subject research, and N of 1 randomized trials: comparisons and contrasts

21 January 2018

1 reference

Economic evaluation alongside n-of-1 trials: getting closer to the margin

21 January 2018

1 reference

Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: impact of bioavailability on costs and outcomes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G003

1 reference

2 August 2017

1 reference